Derek Hicks
EVP, Chief Business Officer at Intellia Therapeutics, Inc. (NTLA) since December 2021
Derek Hicks has filed 6 insider reports with the SEC since December 2021, as EVP and chief Business Officer at Intellia Therapeutics, Inc. (NTLA). Derek Hicks made no open-market purchases or sales in the last 12 months. In the latest filing, on January 7, 2025, Derek Hicks sold 6,502 shares of Intellia Therapeutics, Inc. (NTLA) for $79.2K at an average of $12.18.
- Filings
- 6
- Companies
- 1
- Bought on market
- None
- Sold on market
- $261K
Companies where Derek Hicks is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| EVP, Chief Business Officersince December 2021 | 59,878 | $261K | $9.52 | Jan 7, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jan 3, 2025-$79.2KNTLAEVP, Chief Business Officer Hicks Derek sold $79,194 worth of shares (6,502 units at $12.18), decreasing direct ownership by 10% to 59,878 unitsForm 4Open-market sale
- Mar 1, 2024NTLAHicks Derek was granted 29,393 shares, increasing direct ownership by 79% to 66,380 unitsForm 4Grant or award
- Jan 3, 2024-$114KNTLAHicks Derek sold $114,216 worth of shares (3,877 units at $29.46), decreasing direct ownership by 9% to 36,987 unitsForm 4Open-market sale
- Jan 4, 2023-$67.4KNTLASEC Form 4: Hicks Derek sold $67,425 worth of shares (1,812 units at $37.21), decreasing direct ownership by 9% to 17,306 units to satisfy withholding obligationForm 4Open-market sale
- Jan 3, 2022NTLASEC Form 4: Hicks Derek was granted 19,118 sharesForm 4Grant or award
- Dec 20, 2021NTLADerek Hicks became an insiderForm 3New insider
Compare Derek Hicks with
- Derek Hicks vs John M Leonard1 shared
- Derek Hicks vs Edward J Dulac III1 shared
- Derek Hicks vs Michael P Dube1 shared
- Derek Hicks vs Frank Verwiel1 shared
- Derek Hicks vs Georgia Keresty1 shared
- Derek Hicks vs Jesse Goodman1 shared
Other insiders at the same companies
- John M LeonardNTLA
- Edward J Dulac IIINTLA
- Michael P DubeNTLA
- Frank VerwielNTLA
- Georgia KerestyNTLA
- Jesse GoodmanNTLA
- Brian GoffNTLA
- Fred E CohenNTLA
- William J ChaseNTLA
- Muna BhanjiNTLA
- James BastaNTLA
- Birgit C SchultesNTLA
- David LebwohlNTLA
- Eliana ClarkNTLA
- Laura Sepp-LorenzinoNTLA
Questions about Derek Hicks
- What is Derek Hicks's role at Intellia Therapeutics, Inc.?
- Derek Hicks reports to the SEC as EVP and chief Business Officer at Intellia Therapeutics, Inc. (NTLA), according to the latest filing on January 7, 2025.
- How many shares does Derek Hicks own?
- After the latest filing that states it, Derek Hicks directly owned 59,878 shares of Intellia Therapeutics, Inc. (NTLA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Derek Hicks bought or sold stock recently?
- The most recent open-market sale was on January 3, 2025: sold 6,502 shares of Intellia Therapeutics, Inc. (NTLA) for $79.2K at an average of $12.18.
- How do I get alerts when Derek Hicks files?
- Follow Derek Hicks on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Derek Hicks (SEC CIK 0001901282). Totals count each trade once, skipping amendments whose original is on file, from Dec 29, 2021 on. View on SEC EDGAR · Get this as JSON